| Trial Identifier: | D7990C00006 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04823611 |
| Start Date: | January 2021 |
| Primary Completion Date: | September 2022 |
| Study Completion Date: | September 2022 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version - Part A | |
| English Version - Part B | |
| English Version - Part C | |
| Part A - Japanese Translation | |
| Part B - Japanese Translation | |
| Part C - Japanese Translation |
| Country | Location |
|---|---|
| JP | Chiyoda-ku, JP, 1010041 |
| JP | Chuo-ku, JP, 103-0027 |
| JP | Chuo-ku, JP, 1040031 |
| JP | Chuo-ku, JP, 104-0031 |
| JP | Osaka-shi, JP, 530-0001 |
| JP | Shinjuku-ku, JP, 160-0008 |
| JP | Suita-shi, JP, 565-0853 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company